Literature DB >> 11518189

Delayed preconditioning of myocardium: current perspectives.

G F Baxter1, P Ferdinandy.   

Abstract

The protection conferred by ischemic preconditioning (PC) of myocardium occurs in a bimodal time course. The early cardioprotection wanes rapidly and is succeeded by a delayed phase of protection. This "second window" lasts for up to 72 hours, depending on species and end-point. A widely adopted paradigm for delayed PC is the following: 1) freely diffusible molecules or radicals, generated during the PC period, act in autocrine and/or paracrine manner as triggers of cellular adaptation; 2) they cause the activation of a protein kinase signal cascade; 3) the activated kinases phosphorylate important substrate proteins. In the case of delayed PC, it is thought that the phosphorylation of transcription factors, initiating the synthesis of late appearing effector proteins that promote cell survival during subsequent ischemia, may be a crucial event. Investigation of the proximal components of this sequence has altered our perceptions of several biological mediators, previously thought to be short acting, including adenosine, NO, free radicals and bradykinin. Signal transduction components include protein kinase C, tyrosine kinases and various mitogen- and stress-activated protein kinases but their patterns of regulation are complex and as yet poorly defined. Gene expression is modified in a regulated fashion to induce new proteins that promote cell repair and to protect against subsequent ischemia-reperfusion insult. It is likely that the complex nature of the preconditioning stimulus causes the activation of a variety of transcription factors, regulating a large number of target genes. So far, attention has focussed on a small number of protein products as potential distal mediators of delayed preconditioning. These include the heat shock proteins, manganese superoxide dismutase, inducible nitric oxide synthase, the ATP-sensitive potassium channel and cyclo-oxygenase-2.

Entities:  

Mesh:

Year:  2001        PMID: 11518189     DOI: 10.1007/s003950170041

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  20 in total

Review 1.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Heat shock proteins as emerging therapeutic targets.

Authors:  Csaba Sõti; Enikõ Nagy; Zoltán Giricz; László Vígh; Péter Csermely; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 3.  Botanical flavonoids on coronary heart disease.

Authors:  Chong-Zhi Wang; Sangeeta R Mehendale; Tyler Calway; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2011       Impact factor: 4.667

4.  Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.

Authors:  Harlokesh Narayan Yadav; Manjeet Singh; Pyare Lal Sharma
Journal:  Mol Cell Biochem       Date:  2012-07-19       Impact factor: 3.396

5.  Late phase ischemic preconditioning preserves mitochondrial oxygen metabolism and attenuates post-ischemic myocardial tissue hyperoxygenation.

Authors:  Yuanjing Li; Ming Cai; Yi Xu; Harold M Swartz; Guanglong He
Journal:  Life Sci       Date:  2010-11-02       Impact factor: 5.037

6.  Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS.

Authors:  Yiru Guo; Adam B Stein; Wen-Jian Wu; Xiaoping Zhu; Wei Tan; Qianhong Li; Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-08       Impact factor: 4.733

7.  High doses of ketamine-xylazine anesthesia reduce cardiac ischemia-reperfusion injury in guinea pigs.

Authors:  Ruben C Sloan; Matthew Rosenbaum; Dorcas O'Rourke; Karen Oppelt; Chad R Frasier; Corinne A Waston; Amanda G Allan; David A Brown
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-05       Impact factor: 1.232

8.  Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK).

Authors:  Lasse Solskov; Nils E Magnusson; Steen B Kristiansen; Niels Jessen; Torsten T Nielsen; Ole Schmitz; Hans Erik Bøtker; Sten Lund
Journal:  Mol Cell Biochem       Date:  2011-10-01       Impact factor: 3.396

9.  Preconditioning reduces QTc value in patients with first non-ST-segment elevation myocardial infarction (NSTEMI).

Authors:  Christodoulos E Papadopoulos; Haralampos I Karvounis; Georgios E Parharidis; Georgios E Louridas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

10.  Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.

Authors:  Qianhong Li; Yiru Guo; Wei Tan; Qinghui Ou; Wen-Jian Wu; Diana Sturza; Buddhadeb Dawn; Greg Hunt; Chuanjue Cui; Roberto Bolli
Journal:  Circulation       Date:  2007-09-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.